{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:16:40Z","timestamp":1775708200858,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1016\/s0090-4295(02)01858-7","type":"journal-article","created":{"date-parts":[[2002,10,18]],"date-time":"2002-10-18T21:58:28Z","timestamp":1034978308000},"page":"634-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"title":["Hypoxic prostate\/muscle po2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings"],"prefix":"10.1016","volume":"60","author":[{"given":"Benjamin","family":"Movsas","sequence":"first","affiliation":[]},{"given":"J.Donald","family":"Chapman","sequence":"additional","affiliation":[]},{"given":"Alexandra L","family":"Hanlon","sequence":"additional","affiliation":[]},{"given":"Eric M","family":"Horwitz","sequence":"additional","affiliation":[]},{"given":"Richard E","family":"Greenberg","sequence":"additional","affiliation":[]},{"given":"Corinne","family":"Stobbe","sequence":"additional","affiliation":[]},{"given":"Gerald E","family":"Hanks","sequence":"additional","affiliation":[]},{"given":"Alan","family":"Pollack","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0090-4295(02)01858-7_BIB1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0167-8140(93)90025-4","article-title":"Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix","volume":"26","author":"Hockel","year":"1993","journal-title":"Radiother Oncol"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0167-8140(96)91811-3","article-title":"Oxygenation status predicts radiation response in advanced squamous cell carcinoma of head and neck","volume":"41","author":"Nordsmark","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0360-3016(96)00132-0","article-title":"The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas","volume":"35","author":"Nordsmark","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0959-437X(98)80016-6","article-title":"Master regulator of O2 homeostasis","volume":"8","author":"Semenza","year":"1998","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0090-4295(00)01044-X","article-title":"Increasing hypoxia correlates with increased expression of the angiogenesis marker, VEGF, in human prostate carcinoma","volume":"57","author":"Cvetkovic","year":"2001","journal-title":"Urology"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB6","first-page":"885","article-title":"Imaging tumor hypoxia and tumor perfusion","volume":"34","author":"Groshar","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB7","first-page":"209","article-title":"Measurement of hypoxia in human tumors by SPECT imaging of iodoazomycin arabinoside","volume":"74","author":"Urtasun","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(96)00325-2","article-title":"Quantifying regional hypoxia in human tumors with positron emission tomography of 18F fluoromisonidazole","volume":"36","author":"Rasey","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0090-4295(98)00500-7","article-title":"Hypoxic regions exist in human prostate carcinoma","volume":"53","author":"Movsas","year":"1999","journal-title":"Urology"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB10","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/1097-0142(20001101)89:9<2018::AID-CNCR19>3.0.CO;2-Y","article-title":"Increasing levels of hypoxia in human prostate carcinoma correlate significantly with increasing clinical stage and age","volume":"89","author":"Movsas","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB11","first-page":"338","article-title":"Marking hypoxia in rat prostate carcinomas with B-D-[125I] azomycin galactopyranoside and [99mTc]HL-91","volume":"42","author":"Iyer","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0360-3016(99)00351-X","article-title":"The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis","volume":"46","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB13","first-page":"1","article-title":"Linear and Nonlinear Models for the Analysis of Repeated Measurements","author":"Vonesh","year":"1997"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB14","first-page":"377","article-title":"Oxygenation of human tumors","volume":"166","author":"Vaupel","year":"1990","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0360-3016(01)01968-X","article-title":"A polarographic electrode study of tumor oxygenation in localized prostate cancer","volume":"51","author":"Parker","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/02841869409098433","article-title":"Measurement of human tumour oxygenation status by a polarographic needle electrode","volume":"33","author":"Nordsmark","year":"1994","journal-title":"Acta Oncol"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0360-3016(97)00328-3","article-title":"Heterogeneity of polarographic oxygen tension measurements in cervix cancer","volume":"39","author":"Wong","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0360-3016(95)00106-9","article-title":"Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases","volume":"32","author":"Brizel","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0360-3016(95)00036-X","article-title":"Polarographic needle electrode measurements of oxygen in rate prostate carcinomas; accuracy and reproducibility","volume":"33","author":"Yeh","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB20","first-page":"3316","article-title":"Oxygenation of human tumors","volume":"51","author":"Vaupel","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00005392-200102000-00095","article-title":"Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma","volume":"165","author":"Stewart","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0045(19980401)35:1<1::AID-PROS1>3.0.CO;2-O","article-title":"Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo","volume":"35","author":"Borgstrom","year":"1998","journal-title":"Prostate"},{"key":"10.1016\/S0090-4295(02)01858-7_BIB23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0167-8140(97)00186-2","article-title":"Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays","volume":"46","author":"Chapman","year":"1998","journal-title":"Radiother Oncol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429502018587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429502018587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:39:05Z","timestamp":1758764345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429502018587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0090429502018587"],"URL":"https:\/\/doi.org\/10.1016\/s0090-4295(02)01858-7","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxic prostate\/muscle po2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0090-4295(02)01858-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}